Skip to main content
C-RAD logo

C-RAD — Investor Relations & Filings

Ticker · CRAD ISIN · SE0002016352 LEI · 549300SPXLHF15W2CU25 ST Manufacturing
Open in API
Filings indexed 532 across all filing types
Latest filing 2026-04-10 Annual Report
Country SE Sweden
Listing ST CRAD

About C-RAD

https://c-rad.com/

C-RAD is a medical technology company that develops and supplies solutions for advanced radiation therapy. The company's core offering is its Surface Guided Radiation Therapy (SGRT) technology, which provides high-precision patient positioning, real-time intra-fractional motion management, and respiratory gating. These systems are designed to increase treatment accuracy, enhance patient safety, and improve workflow efficiency in radiation oncology clinics. C-RAD's product portfolio also includes solutions for tumor localization and workflow automation, aiming to help clinicians deliver effective radiotherapy treatments, improve clinical outcomes, and enhance the quality of life for cancer patients.

Recent filings

Filing Released Lang Actions
Annual Report 2026
Annual Report
2026-04-10 Swedish
Kommuniké från extra bolagsstämma i C-Rad AB (publ) den 3 mars 2026
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is a press release titled 'Kommuniké från extra bolagsstämma' (Communiqué from the Extraordinary General Meeting) for C-RAD AB. It details the decisions made during the meeting, specifically regarding an incentive program for the CEO. While it reports on the meeting, it is a formal announcement of the voting results and decisions taken at the meeting, which falls under the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2026-03-03 Swedish
Återköp av aktier av C-RAD AB (publ) under vecka 7, 2026
Transaction in Own Shares Classification · 1% confidence The document is a report on the company's share repurchase activity (buybacks) for a specific week (week 7, 2026). It details the number of shares repurchased, the weighted average price, and the total transaction value, which aligns perfectly with the definition for 'Transaction in Own Shares' (POS).
2026-02-16 Swedish
Interim / Quarterly Report 2025
Interim / Quarterly Report Classification · 1% confidence The document is a 'Bokslutskommuniké' (Year-End Report) for Q4 2025, published by C-RAD AB. It contains comprehensive financial statements, including income statements, balance sheet summaries, and detailed management commentary on financial performance, regional analysis, and future outlook. It is a full quarterly/annual financial report rather than a brief release or an announcement of a report, fitting the definition of an Interim/Quarterly Report (IR). Q4 2025
2026-02-12 Swedish
Audit Report / Information 2025
Audit Report / Information Classification · 1% confidence The document is a 'Year-end report' for C-RAD AB, covering the fourth quarter and the full fiscal year ending December 31, 2025. It contains detailed financial statements, management commentary (CEO comment), and operational performance metrics. Since it covers the full fiscal year and provides comprehensive financial results, it is classified as an Annual Report (10-K equivalent for international reporting). FY 2025
2026-02-12 English
Återköp av aktier av C-RAD AB (publ) under vecka 6, 2026
Transaction in Own Shares Classification · 1% confidence The document is a report detailing the company's share buyback activity (repurchase of own shares) for a specific week (week 6, 2026). It includes a table of daily transaction volumes, weighted average prices, and total transaction values, which is characteristic of a 'Transaction in Own Shares' filing. It explicitly mentions the buyback program and compliance with the EU Market Abuse Regulation.
2026-02-09 Swedish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.